Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
Location: United States, California, San Francisco
Employees: 1-10
Total raised: $53M
Founded date: 2016
Investors 2
Date | Name | Website |
15.07.2021 | Dolby Fami... | dolbyventu... |
- | MRL Ventur... | mrlv.com |
Funding Rounds 2
Date | Series | Amount | Investors |
28.04.2023 | Series A | $36M | Dolby Fami... |
10.05.2021 | Seed | $17M | - |
Mentions in press and media 7
Date | Title | Description | Source |
28.04.2023 | Startup Therini Bio Lands $36M to Take Blood Protein R&D... | The blood protein fibrin plays a key role in stopping bleeding, but in certain circumstance it can a... | medcitynew... |
27.04.2023 | Therini Bio Raises $36M Series A Financing to Develop Fibrin... | - | dolbyventu... |
27.04.2023 | Therini Bio Raises $36M Series A Financing | Therini Bio, a South San Francisco, CA-based biotech company that provides fibrin-targeted therapies... | finsmes.co... |
27.04.2023 | Therini Bio Raises $36M Series A Financing to Develop Fibrin... | Funding from top-tier syndicate will be used to advance potential first-in-class investigational ant... | svhealthin... |
10.05.2021 | Therini Bio Secures $17 Million Investment to Advance Fibrin... | Strengthens investor syndicate with SV's Impact Medicine Fund, MRL Ventures and Sanofi Ventures join... | svhealthin... |
10.05.2021 | Therini Bio Raises $17M in Seed Funding | Therini Bio, Inc., a South San Francisco, CA-based vascular biology company, raised 17m in seed exte... | finsmes.co... |
- | Therini Bio | “Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chro... | fastfounde... |